Literature DB >> 8641489

Production of embryos from in vitro-matured primary human oocytes.

F L Barnes1, A Kausche, J Tiglias, C Wood, L Wilton, A Trounson.   

Abstract

OBJECTIVE: To determine the factors that influence the number and quality of embryos produced from primary oocytes collected from untreated regularly ovulating and irregular or anovulatory polycystic women.
DESIGN: A direct comparison between two patient groups whose oocytes were matured in vitro and a comparison of the embryo development of in vitro-matured oocytes from untreated patients with in vivo-matured oocytes of superovulated IVF-ET patients obtained during the same period.
SETTING: The Monash IVF Clinic, involving patients who expressed the desire to avoid super-ovulation with fertility drugs. MAIN OUTCOME MEASURES: The completion of nuclear maturation of oocytes after 36 or 48 hours culture, fertilization in vitro, and embryo development ratio.
RESULTS: Oocytes from regular cycling patients matured and fertilized at significantly higher rates than irregular cycling and anovulatory women and their embryos had significantly higher mean embryo development ratio. The mean embryo development ratio of embryos of regular cycling patients was similar to superovulated IVF patients but irregular cycling and anovulatory patients had a significantly lower embryo development ratio. Culture of oocytes for 48 hours increased maturation of oocytes from 57% to 82% but did not affect fertilization or cleavage rates. Embryo development was not affected significantly by the grade of follicular cell cover of oocytes.
CONCLUSIONS: The developmental capability of primary oocytes is higher in regular cycling women than in irregular cycling and anovulatory women with polycystic ovary disease.

Entities:  

Mesh:

Year:  1996        PMID: 8641489     DOI: 10.1016/s0015-0282(16)58330-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  22 in total

1.  Development of a well-defined medium for the in vitro maturation of immature bovine cumulus-oocyte complexes.

Authors:  A Chanson; D Nocera; A Senn; P De Grandi; M Germond
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

2.  Retrieval, maturation, and fertilization of immature oocytes obtained from unstimulated patients with polycystic ovary syndrome.

Authors:  N G Beckers; M H Pieters; L Ramos; G H Zeilmaker; B C Fauser; D D Braat
Journal:  J Assist Reprod Genet       Date:  1999-02       Impact factor: 3.412

3.  Extended in vitro maturation of immature oocytes from stimulated cycles: an analysis of fertilization potential, embryo development, and reproductive outcomes.

Authors:  David E Reichman; Joseph Politch; Elizabeth S Ginsburg; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2010-04-28       Impact factor: 3.412

4.  Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment.

Authors:  Rubens Fadini; Ruggero Comi; Mario Mignini Renzini; Giovanni Coticchio; Marilena Crippa; Elena De Ponti; Mariabeatrice Dal Canto
Journal:  J Assist Reprod Genet       Date:  2011-06-15       Impact factor: 3.412

5.  Comparison of aneuploidy frequencies between in vitro matured and unstimulated cycles oocytes by metaphase comparative genomic hybridization (mCGH).

Authors:  Tahsin Yakut; Mutlu Karkucak; Geoffrey Sher; Levent Keskintepe
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

6.  Pregnancies resulting from in vitro matured oocytes collected from women with regular menstrual cycle.

Authors:  H G Yoon; S H Yoon; W Y Son; S W Lee; S P Park; K S Im; J H Lim
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

Review 7.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

8.  What is the optimal threshold of serum Anti-Müllerian hormone (AMH) necessary for IVM treatments?

Authors:  Alon Kedem; Gil M Yerushalmi; Ettie Maman; Rina Hemi; Mirit Hanochi; Ariel Hourvitz
Journal:  J Assist Reprod Genet       Date:  2013-04-23       Impact factor: 3.412

9.  Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes.

Authors:  Pallop Pongsuthirak; Sorramon Songveeratham; Teraporn Vutyavanich
Journal:  Reprod Sci       Date:  2014-07-11       Impact factor: 3.060

10.  Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring.

Authors:  Adam J Watkins; Adrian Wilkins; Colm Cunningham; V Hugh Perry; Meei J Seet; Clive Osmond; Judith J Eckert; Christopher Torrens; Felino R A Cagampang; Jane Cleal; William P Gray; Mark A Hanson; Tom P Fleming
Journal:  J Physiol       Date:  2008-02-28       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.